PL2440562T3 - Otrzymywanie 6-alfa-amino-N-podstawionych morfinanów w wyniku katalitycznego przeniesienia wodoru - Google Patents

Otrzymywanie 6-alfa-amino-N-podstawionych morfinanów w wyniku katalitycznego przeniesienia wodoru

Info

Publication number
PL2440562T3
PL2440562T3 PL10724967T PL10724967T PL2440562T3 PL 2440562 T3 PL2440562 T3 PL 2440562T3 PL 10724967 T PL10724967 T PL 10724967T PL 10724967 T PL10724967 T PL 10724967T PL 2440562 T3 PL2440562 T3 PL 2440562T3
Authority
PL
Poland
Prior art keywords
alpha
amino
preparation
hydrogen transfer
catalytic hydrogen
Prior art date
Application number
PL10724967T
Other languages
English (en)
Inventor
Christopher W. Grote
Gary L. Cantrell
Joseph P. Mcclurg
Catherine E. Thomasson
Frank W. Moser
Original Assignee
Mallinckrodt Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Llc filed Critical Mallinckrodt Llc
Publication of PL2440562T3 publication Critical patent/PL2440562T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
PL10724967T 2009-06-11 2010-06-10 Otrzymywanie 6-alfa-amino-N-podstawionych morfinanów w wyniku katalitycznego przeniesienia wodoru PL2440562T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18609109P 2009-06-11 2009-06-11
EP10724967.4A EP2440562B1 (en) 2009-06-11 2010-06-10 Preparation of 6-alpha-amino n-substituted morphinans by catalytic hydrogen transfer

Publications (1)

Publication Number Publication Date
PL2440562T3 true PL2440562T3 (pl) 2017-07-31

Family

ID=42357348

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10724967T PL2440562T3 (pl) 2009-06-11 2010-06-10 Otrzymywanie 6-alfa-amino-N-podstawionych morfinanów w wyniku katalitycznego przeniesienia wodoru

Country Status (8)

Country Link
US (1) US8519133B2 (pl)
EP (1) EP2440562B1 (pl)
JP (2) JP5697215B2 (pl)
CN (1) CN102803267A (pl)
CA (1) CA2764915C (pl)
ES (1) ES2598496T3 (pl)
PL (1) PL2440562T3 (pl)
WO (1) WO2010144641A1 (pl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8946419B2 (en) 2009-02-23 2015-02-03 Mallinckrodt Llc (+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives
US8519133B2 (en) * 2009-06-11 2013-08-27 Mallinckrodt Llc Preparation of 6-alpha-amino N-substituted morphinans by catalytic hydrogen transfer
US8471023B2 (en) * 2009-06-11 2013-06-25 Mallinckrodt Llc Reductive amination of 6-keto normorphinans by catalytic hydrogen transfer
US10363251B2 (en) 2009-07-16 2019-07-30 Mallinckrodt Llc (+)-morphinans as antagonists of toll-like receptor 9 and therapeutic uses thereof
NO2453895T3 (pl) * 2009-07-16 2018-10-20
US8829020B2 (en) 2009-07-16 2014-09-09 Mallinckrodt Llc Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers
US9700508B2 (en) 2010-05-10 2017-07-11 Euro-Celtique S.A. Pharmaceutical compositions comprising hydromorphone and naloxone
EP2568965A1 (en) 2010-05-10 2013-03-20 Euro-Celtique S.A. Combination of active loaded granules with additional actives
PH12012502083A1 (en) 2010-05-10 2017-07-26 Euro Celtique Sa Manufacturing of active-free granules and tablets comprising the same
AU2010357625B2 (en) * 2010-07-16 2015-04-23 Mallinckrodt Llc (+)-morphinans as antagonists of Toll-like receptor 9 and therapeutic uses thereof
KR20140036215A (ko) * 2011-06-09 2014-03-25 말린크로트 엘엘씨 촉매 수소 전달에 의한 6-케토 모르피난의 환원 아미노화
WO2015071380A1 (en) 2013-11-13 2015-05-21 Euro-Celtique S.A. Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome
DK3166923T3 (da) * 2014-07-10 2023-04-11 SpecGx LLC Fremgangsmåde til fremstilling af substituerede phenylalkaner
WO2020205735A1 (en) * 2019-03-29 2020-10-08 Humanwell Pharmaceutical US Novel morphinans useful for treating medical disorders
CN115521317B (zh) * 2021-02-02 2025-07-25 山东新时代药业有限公司 一种制备纳呋拉啡中间体的方法
CN119350353B (zh) * 2024-10-09 2026-04-03 北京阳光诺和药物研究股份有限公司 一种盐酸纳法拉芬中间体及其制备方法

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2578787A (en) * 1949-04-09 1951-12-18 Rohm & Haas Reduction of enamines
DE922827C (de) 1951-02-08 1955-01-27 Knoll Ag Verfahren zur Herstellung von quartaeren Ammoniumsalzen, die 2 Tetrahydroisochinolinreste enthalten
US2772270A (en) * 1954-10-21 1956-11-27 M J Lewenstein 14-hydroxymorphinone and 8, 14-dihydroxydihydromorphinone
JPS417786B1 (pl) 1964-02-03 1966-04-25
JPS416905B1 (pl) 1964-02-03 1966-04-19
US3717643A (en) * 1967-05-04 1973-02-20 Sterling Drug Inc N-substituted-norapomorphines
US4089855A (en) * 1976-04-23 1978-05-16 Cornell Research Foundation, Inc. Process for the stereoselective reduction of 6- and 8-keto morphine and morphinan derivatives with formamidinesulfinic acid and compounds obtained thereby
EP0034480A3 (en) 1980-02-14 1982-01-13 Grigg, Ronald Ernest Alkylation of amines
US4521601A (en) * 1981-05-20 1985-06-04 The United States Of America As Represented By The Department Of Health & Human Services Practical total synthesis unnatural enantiomers of opium-derived morphinans
US4795813A (en) * 1981-08-17 1989-01-03 The Florida Board Of Regents On Behalf Of The Florida State University Synthesis of derivatives of codeine and other 3-O-alkylmorphines
US4443605A (en) * 1982-07-30 1984-04-17 Miles Laboratories, Inc. 7β-Arylalkyl-6α, 7 α-oxymethylene-3-methoxy or 3-hydroxy-4, 5α-epoxy-17 methyl or 17-cycloalkyl-methyl morphinans
US4775759A (en) * 1984-11-27 1988-10-04 The United States Of America As Represented By The Department Of Health And Human Services Synthesis and utilization of 17-methyl and 17-cyclopropylmethyl-3,14-dihydroxy-4,5α-epoxy 6β-fluoromorphinans (foxy and cyclofoxy) as (18F)-labeled opioid ligands for position emission transaxial tomography (PETT)
US4673679A (en) * 1986-05-14 1987-06-16 E. I. Du Pont De Nemours And Company Use of prodrugs of 3-hydroxymorphinans to prevent bitter taste upon buccal, nasal or sublingual administration
US5668285A (en) * 1986-10-31 1997-09-16 The United States Of America As Represented By The Department Of Health And Human Services Total synthesis of northebaine, normophine, noroxymorphone enantiomers and derivatives via N-Nor intermediates
US4912114A (en) * 1988-03-18 1990-03-27 Sandoz Ltd. Morphinan derivatives
US4991391A (en) * 1989-01-27 1991-02-12 Westinghouse Electric Corp. System for cooling in a gas turbine
US5208338A (en) * 1991-06-14 1993-05-04 The United States Of America As Represented By The Department Of Health & Human Services. Radiolabeled N-substituted-6-iodo-3,14-dihydroxy-4,5α-epoxymorphinans
DE4132159A1 (de) * 1991-09-27 1993-04-01 Boehringer Ingelheim Kg 14-hydroxy-n-(2-methoxyethyl)-7,8-dihydromorphin und -norisomorphin, verfahren zu deren herstellung und deren verwendung als arzneimittel
ES2121988T3 (es) * 1992-01-23 1998-12-16 Toray Industries Derivado de morfinano y uso medicinal.
NZ268969A (en) * 1993-07-23 1997-06-24 Toray Industries Morphinan derivatives and pharmaceutical compositions
HU224914B1 (en) * 1994-05-31 2006-04-28 Mallinckrodt Chemical Inc Process for the preparation of nalbuphine having not more then 1% levels of beta-epimer
CN1045442C (zh) 1994-07-20 1999-10-06 中国科学院上海药物研究所 左、右旋氯斯库利啉及它的制备方法和用途
WO1997020789A1 (en) * 1995-12-06 1997-06-12 Japan Science And Technology Corporation Process for preparating optically active compounds
DE19548399A1 (de) * 1995-12-22 1997-06-26 Basf Ag Rutheniumkomplexe mit einem chiralen, zweizähnigen Phosphinoxazolin-Liganden zur enantioselektiven Transferhydrierung von prochiralen Ketonen
GB9616253D0 (en) * 1996-08-01 1996-09-11 Johnson Matthey Plc Preparation of narcotic analgesics
PT102006B (pt) 1997-05-19 2000-06-30 Hovione Sociedade Quimica S A Novo processo de preparacao de azitromicina
GB9821067D0 (en) * 1998-09-29 1998-11-18 Zeneca Ltd Transfer hydrogenation process
DE10138140A1 (de) * 2001-08-09 2003-02-20 Degussa Verfahren zur Herstellung von Aminen durch reduktive Aminierung von Carbonylverbindungen unter Transfer-Hydrierungsbedingungen
DE10161963A1 (de) * 2001-12-17 2003-07-03 Johannes Schuetz 6-Aminomorphinanderivate, Herstellungsverfahren dafür und deren Verwendung
CA2520030A1 (en) * 2003-03-26 2004-10-07 Pharmacia & Upjohn Company Llc Process to produce enantiomerically enriched alcohols and amines
US20060182692A1 (en) * 2003-12-16 2006-08-17 Fishburn C S Chemically modified small molecules
SK286047B6 (sk) 2004-04-13 2008-01-07 Zentiva, A. S. Spôsob prípravy derivátov 4,5alfa-epoxy-6-oxomorfínanu
US6887999B1 (en) * 2004-05-21 2005-05-03 Acura Pharmaceuticals, Inc. Preparation of dihydrocodeine from codeine
EP1781615A1 (en) * 2004-07-23 2007-05-09 Pliva Istrazivanje i Razvoj d.o.o. Novel form of a benzenesulfonamide derivative
GB0421687D0 (en) * 2004-09-30 2004-11-03 Johnson Matthey Plc Preparation of opiate analgesics
PT2251330E (pt) 2004-11-05 2012-07-20 Rensselaer Polytech Inst 4-hidroxibenzomorfanos
EP1762569A1 (en) * 2005-09-12 2007-03-14 Alcasynn Pharmaceuticals Gmbh Novel 6-amino-morphinan derivatives, method of manufacturing them and their application as analgesics
CA2652849A1 (en) * 2006-05-25 2007-12-06 Alpharma (Bermuda) Investments Ltd. Process useful in the preparation of morphinan antagonists
ES2407033T3 (es) * 2007-05-04 2013-06-11 Mallinckrodt Llc Procedimientos mejorados para la preparación de opiáceos 6-alfa-hidroxi-n-alquilados
JP2010533719A (ja) * 2007-07-17 2010-10-28 マリンクロッド・インコーポレイテッド 還元的アミノ化によるｎ−アルキル化オピエートの調製
NZ607842A (en) * 2008-09-30 2013-12-20 Mallinckrodt Llc Processes for the selective amination of ketomorphinans
US8563724B2 (en) * 2009-02-23 2013-10-22 Mallinckrodt Llc (+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives
US8519133B2 (en) * 2009-06-11 2013-08-27 Mallinckrodt Llc Preparation of 6-alpha-amino N-substituted morphinans by catalytic hydrogen transfer

Also Published As

Publication number Publication date
ES2598496T3 (es) 2017-01-27
EP2440562A1 (en) 2012-04-18
JP2012529533A (ja) 2012-11-22
CN102803267A (zh) 2012-11-28
JP5697215B2 (ja) 2015-04-08
WO2010144641A1 (en) 2010-12-16
US8519133B2 (en) 2013-08-27
EP2440562B1 (en) 2016-08-10
JP2015057448A (ja) 2015-03-26
CA2764915C (en) 2017-07-11
CA2764915A1 (en) 2010-12-16
US20100317683A1 (en) 2010-12-16

Similar Documents

Publication Publication Date Title
PL2440562T3 (pl) Otrzymywanie 6-alfa-amino-N-podstawionych morfinanów w wyniku katalitycznego przeniesienia wodoru
EP2455953A4 (en) REACTOR
ZA201109334B (en) Dosage forms of apixaban
PL2494832T3 (pl) Planowanie komunikacji bezpośrednie-do-bezpośredniego
GB0907539D0 (en) Catalyst preparation method
GB0921836D0 (en) Anaerobic reactor
EP2421005A4 (en) REACTOR
GB0904624D0 (en) Gas capsule
IL219921A0 (en) Abt-263 capsule
GB2474550B (en) Methods for preparing bromfenec sodium polymorph
EP2514719A4 (en) PROCESS FOR SYNTHESIS OF AMMONIA
EP2440415A4 (en) MATRIX ALIGNMENT
GB0910078D0 (en) Uses of mannose-6-phosphate
GB0922023D0 (en) Preparation of n-monofluoroalkyl compounds
SG10201403320RA (en) Process For Preparing N-Substituted Cyclic Imides
PL2440561T3 (pl) Redukcyjne aminowanie 6-keto-normorfinanow przez katalityczne przeniesienie wodoru
EP2459540A4 (en) PREPARATION OF FIPAMEZOLE
SI2504309T1 (sl) Sinteza acetokslacetaldehida
EP2404891A4 (en) PROCESS FOR THE PREPARATION OF ACYLBENZENES
PL2515686T3 (pl) System reaktora do elektroporacji
TWM372834U (en) Structure of bottle plug
TWM372743U (en) Improved structure of Kendama
ZA201308473B (en) Reductive amination of 6-keto morphinans by catalytic hydrogen transfer
TWM365675U (en) Improved structure of teapoy
IL215100A0 (en) Improved chemical synthesis of diazaindoles by chichibabin cyclization